Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Adherence news

Show

From To
Adults with HIV who have compassionate care providers start and remain in treatment longer

Researchers find patients who perceive their primary care providers as lacking empathy and not willing to include them in decision making are at risk for abandoning treatment or not seeking treatment at all.

Published
14 hours ago
From
ScienceDaily
One in five Americans living with HIV experience severe anxiety on an almost daily basis

A fifth of HIV-positive adults in the United States regularly experience symptoms of anxiety, according to research published in AIDS. Individuals with symptoms of generalised anxiety disorder (GAD)

Published
04 July 2019
By
Michael Carter
Researchers Discuss Ethics and Privacy Concerns About the Growing Field of HIV Adherence Monitoring

We have several ways to measure adherence to treatment or pre-exposure prophylaxis (PrEP). But as technology changes, and the fields of HIV medicine and public health focus increasingly on monitoring viral suppression or drug concentrations in the body for PrEP, the questions about the ethics of certain technologies, their uses, and what happens to that data are still being debated.

Published
25 June 2019
From
The Body Pro
Following an HIV treatment interruption, most children recover immunologically

Just over one in ten (12%) children and adolescents living with HIV in Europe and Thailand take a break from antiretroviral treatment, usually as a result of

Published
07 June 2019
By
Carole Leach-Lemens
High prevalence of stockouts of antiretroviral medicines in South Africa

One in five public health facilities in South Africa were unable to supply at least one antiretroviral (ARV) or tuberculosis (TB) drug on the day they were contacted

Published
23 May 2019
By
Alain Volny-Anne
Many Women on HIV Treatment Are at Risk of Developing a Detectable Viral Load

An ongoing study finds that considerable challenges in such women’s lives may compromise their adherence to antiretrovirals.

Published
22 May 2019
From
Poz
NIH Trial Evaluates Long-acting HIV Medication Unable to Adhere to Strict Daily Regimens

A clinical trial to evaluate long-acting antiretroviral therapy (ART) for maintaining HIV suppression in people for whom adhering to conventional daily oral ART has been a challenge has begun at research sites across the United States. The study, called Long-Acting Therapy to Improve Treatment Success in Daily Life, or LATITUDE, will help determine whether a combination of two experimental injectable formulations of ART are superior to conventional oral ART in managing HIV infection in this population.

Published
09 May 2019
From
National Institute of Allergy and Infectious Diseases
Most UK clinic staff now tell people about U=U, but not always in the same way

Two presentations at this month’s British HIV Association (BHIVA) conference in Bournemouth show that most specialist healthcare workers are now informing people with HIV that if their

Published
29 April 2019
By
Gus Cairns
Naltrexone implants provide better HIV treatment outcomes for those with HIV and opioid addiction in Russia

A double-blind, placebo-controlled randomised trial conducted in Russia found that slow-release naltrexone implants resulted in better HIV treatment outcomes for people living with HIV and opioid dependence when compared

Published
19 April 2019
By
Krishen Samuel
Older black HIV-positive women have more mental distress than other women with HIV, but get less help for it

A study looking at women aged over 45 living with HIV in the UK has found that while black African and Caribbean women experience greater social isolation

Published
17 April 2019
By
Gus Cairns
← First12345...44Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.